Details van artikel 169 van 1438 gevonden artikelen
PCN97 COST EFFECTIVENESS OF ERLOTINIB TREATMENT GIVEN BY A CLINICALLY BASED APPROACH AND AN EGFR/KRAS TESTING-GUIDED APPROACH ADVANCED IN NON SMALL-CELL LUNG CANCER: A PROSPECTIVE MULTICENTRIC FRENCH STUDY (ERMETIC)
Titel:
PCN97 COST EFFECTIVENESS OF ERLOTINIB TREATMENT GIVEN BY A CLINICALLY BASED APPROACH AND AN EGFR/KRAS TESTING-GUIDED APPROACH ADVANCED IN NON SMALL-CELL LUNG CANCER: A PROSPECTIVE MULTICENTRIC FRENCH STUDY (ERMETIC)
Auteur:
Borget, I Cadranel, J Pignon, JP Danton, G Coudert, B Dansin, E Friard, S Daniel, C Quoix, E Madeleine, J Madroszyk, A Morin, F Chouaid, C
Verschenen in:
Value in health
Paginering:
Jaargang 12 (2009) nr. 7 pagina's 1 p.
Jaar:
2009
Inhoud:
Uitgever:
International Society for Pharmacoeconomics and Outcomes Research (ISPOR)
Bronbestand:
Elektronische Wetenschappelijke Tijdschriften
Details van artikel 169 van 1438 gevonden artikelen